Research Topics
| Gwen L NicholsSummaryAffiliation: Columbia University Country: USA Publications
|
Detail Information
Publications
Tyrosine kinase inhibitors as cancer therapyGwen L Nichols
Department of Medicine, Divisions of Hematology and Oncology, Columbia University College of Physicians and Surgeons, New York, New York, USA
Cancer Invest 21:758-71. 2003
Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyureaMichael J Flamm
Department of Medicine, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, 650 W, 168th Street BB 20 08, New York, NY, 10032, USA
Leuk Res 26:417-20. 2002..We report a case of secondary Ph - ve MDS/AML during blast crisis in a patient treated with hydroxyurea for CML...
Unusual uterine recurrence of primary central nervous system lymphomaGwen L Nichols
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Clin Adv Hematol Oncol 4:697-8, discussion 699-700. 2006
The advisory dean program: a personalized approach to academic and career advising for medical studentsWilliam Macaulay
Department of Orthopaedic Surgery, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Acad Med 82:718-22. 2007..Expecting to further improve on this early positive response, the AD Program will continue to foster an environment conducive to a seamless transition from student to physician...
Modulation of the activity of Bcl-2 in Waldenstrom's macroglobulinemia using antisense oligonucleotidesGwen L Nichols
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
Semin Oncol 30:297-9. 2003..Bcl-2 downregulation via G3139 antisense treatment may have potential anticancer efficacy in WM and further studies to address its effects on clinical specimens are warranted, in anticipation of using this agent in WM clinical trials...
